Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses.
Gauvreau GM, Boulet LP, Cockcroft DW, Baatjes A, Cote J, Deschesnes F, Davis B, Strinich T, Howie K, Duong M, Watson RM, Renzi PM, O'Byrne PM.
Gauvreau GM, et al. Among authors: cockcroft dw.
Am J Respir Crit Care Med. 2008 May 1;177(9):952-8. doi: 10.1164/rccm.200708-1251OC. Epub 2008 Jan 31.
Am J Respir Crit Care Med. 2008.
PMID: 18244953
Clinical Trial.